Kukje Pharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	99,165	87,559	103,034	119,890	106,115	112,861
Market Cap Growth	-1.22%	-15.02%	-14.06%	12.98%	-5.98%	-36.19%
Enterprise Value	118,859	99,924	124,008	140,751	127,215	143,804
Last Close Price	4870.00	4273.70	4997.94	5847.40	5173.86	5500.86
PE Ratio	17.39	15.37	19.80	-	29.83	-
PS Ratio	0.57	0.50	0.66	0.89	0.84	0.94
PB Ratio	1.01	0.90	1.15	1.41	1.43	1.65
P/TBV Ratio	1.03	0.91	1.16	1.43	1.45	1.67
P/FCF Ratio	44.74	39.51	100.14	47.40	20.23	14.65
P/OCF Ratio	16.99	15.01	26.15	33.53	16.32	11.76
EV/Sales Ratio	0.68	0.57	0.79	1.04	1.00	1.20
EV/EBITDA Ratio	12.63	10.62	12.52	63.55	13.03	52.42
EV/EBIT Ratio	19.22	16.16	18.50	-	24.13	-
EV/FCF Ratio	53.63	45.09	120.53	55.65	24.26	18.66
Debt / Equity Ratio	0.31	0.31	0.33	0.36	0.39	0.53
Debt / EBITDA Ratio	3.23	3.23	2.98	13.84	2.93	13.12
Debt / FCF Ratio	13.72	13.72	28.68	12.12	5.45	4.67
Net Debt / Equity Ratio	0.20	0.20	0.23	0.24	0.31	0.41
Net Debt / EBITDA Ratio	2.09	2.09	2.10	9.04	2.36	10.24
Net Debt / FCF Ratio	8.88	8.88	20.17	7.92	4.39	3.65
Asset Turnover	1.01	1.01	0.95	0.90	0.92	0.84
Inventory Turnover	3.40	3.40	3.39	3.14	3.27	3.42
Quick Ratio	0.63	0.63	1.13	0.53	0.54	0.58
Current Ratio	1.09	1.09	2.00	0.92	1.01	0.88
Return on Equity (ROE)	6.09%	6.09%	5.97%	-10.58%	4.97%	-2.24%
Return on Assets (ROA)	2.22%	2.22%	2.55%	-0.83%	2.38%	-0.73%
Return on Invested Capital (ROIC)	4.87%	4.81%	4.90%	-1.97%	4.06%	-1.67%
Return on Capital Employed (ROCE)	5.10%	5.10%	4.90%	-1.90%	5.90%	-2.00%
Earnings Yield	5.75%	6.51%	5.05%	-7.02%	3.35%	-1.38%
FCF Yield	2.23%	2.53%	1.00%	2.11%	4.94%	6.83%
Payout Ratio	10.72%	10.72%	-	-	-	-
Buyback Yield / Dilution	-0.08%	-0.08%	-0.39%	0.03%	0.03%	0.03%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.